Several scoring systems have been developed to assess the prognosis of AMI-CS patients (22–25), and prognostic factors vary, including age, smoking, hypertension, diabetes, stroke history, heart rate (HR), lactate levels, pH, coagulation function, urea nitrogen, NT-proBNP, and others. This evidence concerns the gene NPPB and hypertensive disorder.